Temozolomide: all 659 studies that test it

Page 2 of 7. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• A Study of the Drugs Talazoparib and Temozolomide in Prostate CancerTerminatedNCT04019327Phase 1/2Results posted
• Capecitabine and Temozolomide for Treatment of Recurrent Pituitary AdenomasTerminatedNCT03930771Phase 2Results posted
• Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated GliomaTerminatedNCT03927222Phase 2Results posted
• A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine LeiomyosarcomaActive, not recruitingNCT03880019Phase 2Results posted
• 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation TherapyCompletedNCT03778294Phase 2Results posted
• Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With GlioblastomaCompletedNCT03746080Phase 2Results posted
• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsCompletedNCT03709680Phase 2Results posted
• Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBMTerminatedNCT03705351Phase 1Results posted
• Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 MutationsActive, not recruitingNCT03581292Phase 2Results posted
• Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)CompletedNCT03556384Phase 2Results posted
• M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung CancersCompletedNCT03554473Phase 1/2Results posted
• A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and TemozolomideTerminatedNCT03495921Phase 3Results posted
• Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed GlioblastomaCompletedNCT03463265Phase 2Results posted
• Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed GlioblastomaCompletedNCT03426891Phase 1Results posted
• Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma MultiformeTerminatedNCT03363659Phase 2Results posted
• Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomaCompletedNCT03323034Phase 1Results posted
• T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic RadiosurgeryTerminatedNCT03190967Phase 1/2Results posted
• Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in GliomaTerminatedNCT03168919Not applicableResults posted
• A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent GlioblastomaCompletedNCT03150862Phase 1/2Results posted
• Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT03150810Phase 1Results posted
• Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed GlioblastomaCompletedNCT03139916Phase 2Results posted
• Spectroscopic MRI-Guided Radiation Therapy Planning in GlioblastomaCompletedNCT03137888Phase 2Results posted
• BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent GlioblastomaTerminatedNCT03119064Phase 1/2Results posted
• Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsCompletedNCT02975882Phase 1Results posted
• Peptide Targets for Glioblastoma Against Novel Cytomegalovirus AntigensTerminatedNCT02864368Phase 1Results posted
• A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With GlioblastomaCompletedNCT02805179Phase 2Results posted
• Temozolomide Chronotherapy for High Grade GliomaCompletedNCT02781792Phase 2Results posted
• Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT02715609Phase 1/2Results posted
• Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.CompletedNCT02698410Phase 2Results posted
• Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With GlioblastomaCompletedNCT02661282Phase 1/2Results posted
• Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine CarcinomasActive, not recruitingNCT02595424Phase 2Results posted
• A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's SarcomaCompletedNCT02511132Phase 2Results posted
• SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT02455557Phase 2Results posted
• Methoxyamine and Temozolomide in Treating Patients With Recurrent GlioblastomaTerminatedNCT02395692Phase 2Results posted
• Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson AdministrationCompletedNCT02389738Early Phase 1Results posted
• A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)TerminatedNCT02343549Phase 2Results posted
• Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade GliomasCompletedNCT02343406Phase 2Results posted
• Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous SystemCompletedNCT02343081Phase 4Results posted
• Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent GlioblastomaTerminatedNCT02340156Phase 2Results posted
• A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed GlioblastomaCompletedNCT02315534Phase 1/2Results posted
• Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NETCompletedNCT02231762Phase 2Results posted
• Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.CompletedNCT02209948Phase 2Results posted
• IDH1 Peptide Vaccine for Recurrent Grade II GliomaCompletedNCT02193347Phase 1Results posted
• Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade GliomaTerminatedNCT02168270Phase 1Results posted
• Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeActive, not recruitingNCT02152982Phase 2/3Results posted
• Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent MalignanciesCompletedNCT02116777Phase 1/2Results posted
• Everolimus With and Without Temozolomide in Adult Low Grade GliomaTerminatedNCT02023905Phase 2Results posted
• 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation TherapyCompletedNCT01991977Phase 2Results posted
• Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade GliomaCompletedNCT01977677Phase 1/2Results posted
• Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell TumorsCompletedNCT01946529Phase 2Results posted
• Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by SurgeryCompletedNCT01835145Phase 2Results posted
• MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene VariationsCompletedNCT01827384Phase 2Results posted
• A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT01790503Phase 1/2Results posted
• Preoperative CRT With Temozolomide Plus Capecitabine in Rectal CancerCompletedNCT01781403Phase 1Results posted
• Bevacizumab Beyond Progression (BBP)CompletedNCT01740258Phase 2Results posted
• Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002)CompletedNCT01704287Phase 2Results posted
• Study of MLN8237 in Combination With Irinotecan and TemozolomideCompletedNCT01601535Phase 1/2Results posted
• Doxycycline, Temozolomide and Ipilimumab in MelanomaTerminatedNCT01590082Phase 1/2Results posted
• Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)CompletedNCT01550224Phase 2Results posted
• Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsCompletedNCT01525082Phase 2Results posted
• Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine GliomasCompletedNCT01514201Phase 1/2Results posted
• Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerCompletedNCT01506609Phase 2Results posted
• Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent GliomasTerminatedNCT01478321Phase 2Results posted
• Low Dose Radiation Therapy for Glioblastoma MultiformeCompletedNCT01466686Phase 2Results posted
• Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By SurgeryCompletedNCT01465659Phase 1/2Results posted
• Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive GlioblastomaCompletedNCT01342757Not applicableResults posted
• Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT01328535Phase 2Results posted
• Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings SarcomaTerminatedNCT01313884Phase 2Results posted
• A Safety Study in Participants With Advanced Solid TumorsTerminatedNCT01284335Phase 1Results posted
• The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS LymphomaTerminatedNCT01235793Phase 2Results posted
• Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma MultiformeCompletedNCT01209442Phase 2Results posted
• ABT-888 and Temozolomide for Liver CancerTerminatedNCT01205828Phase 2Results posted
• Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT01196416Phase 1/2Results posted
• Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)TerminatedNCT01186406Phase 2Results posted
• Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)TerminatedNCT01182350Phase 2Results posted
• Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the EyeCompletedNCT01143402Phase 2Results posted
• Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid TumorsTerminatedNCT01127178Phase 1Results posted
• High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With MelanomaCompletedNCT01124734Phase 2Results posted
• Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma MultiformCompletedNCT01120639Phase 1/2Results posted
• Ipilimumab + Temozolomide in Metastatic MelanomaCompletedNCT01119508Phase 2Results posted
• A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma MultiformeCompletedNCT01115491Phase 2Results posted
• Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory NeuroblastomaCompletedNCT01114555Phase 2Results posted
• Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)TerminatedNCT01110876Phase 1/2Results posted
• Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade GliomaTerminatedNCT01105702Phase 2Results posted
• Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic RhabdomyosarcomaCompletedNCT01055314Phase 2Results posted
• A Study of ABT-888 in Combination With Temozolomide for Colorectal CancerCompletedNCT01051596Phase 2Results posted
• A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent GlioblastomaTerminatedNCT01044966Phase 1/2Results posted
• Veliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaCompletedNCT01026493Phase 1/2Results posted
• Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases TreatmentCompletedNCT01015534Phase 2Results posted
• Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus TumorsTerminatedNCT01014767Phase 3Results posted
• Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01013285Phase 2Results posted
• ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast CancerCompletedNCT01009788Phase 2Results posted
• Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic MelanomaTerminatedNCT01009515Phase 2Results posted
• Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for GlioblastomaCompletedNCT01004874Phase 2Results posted
• Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00998010Phase 2Results posted
• A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginCompletedNCT00993044Phase 1Results posted
• Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & TemozolomideCompletedNCT00990652Phase 2Results posted
• Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma MultiformeCompletedNCT00979017Phase 2Results posted
• Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma MultiformCompletedNCT00977431Phase 1Results posted
• Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and PanobinostatTerminatedNCT00925132Phase 1/2Results posted

← Temozolomide overview